Kiniksa Pharmaceuticals, Ltd. Stock price
Equities
KNSA
BMG5269C1010
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.73 USD | -1.30% | -0.35% | +12.49% |
Feb. 28 | Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase | MT |
Feb. 28 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q4 2023 Earnings Call, Feb 28, 2024 |
Financials (USD)
Sales 2024 * | 383M | Sales 2025 * | 513M | Capitalization | 1.39B |
---|---|---|---|---|---|
Net income 2024 * | -10M | Net income 2025 * | 2M | EV / Sales 2024 * | 3.02 x |
Net cash position 2024 * | 236M | Net cash position 2025 * | 378M | EV / Sales 2025 * | 1.98 x |
P/E ratio 2024 * |
-122
x | P/E ratio 2025 * |
335
x | Employees | 297 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.39% |
Latest transcript on Kiniksa Pharmaceuticals, Ltd.
1 day | -1.30% | ||
1 week | -0.35% | ||
Current month | -6.67% | ||
1 month | -3.09% | ||
3 months | +10.53% | ||
6 months | +13.26% | ||
Current year | +12.49% |
Managers | Title | Age | Since |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 15-06-30 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 15-06-30 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 15-09-30 |
Barry D. Quart
BRD | Director/Board Member | 67 | 15-09-30 |
Thomas Malley
BRD | Director/Board Member | 55 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 19.73 | -1.30% | 359,719 |
24-03-27 | 19.99 | +0.10% | 358,398 |
24-03-26 | 19.97 | +0.05% | 406,095 |
24-03-25 | 19.96 | -0.05% | 235,567 |
24-03-22 | 19.97 | +0.86% | 350,736 |
Delayed Quote Nasdaq, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.49% | 1.39B | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |